Loading organizations...
Key people at Ganot.
Ganot Capital is a family-owned investment firm based in Hollywood, Florida, that specializes in buyouts, growth capital, and venture capital across the healthcare and senior care sectors. The firm acquires and invests in diverse assets, including healthcare real estate, medical device manufacturers, digital health technologies, and biopharmaceutical companies. Operating with an estimated annual revenue of under $5 million and a team of fewer than 25 employees, the organization manages a concentrated international portfolio that currently includes two active Israeli companies and one recorded exit. Under the strategic leadership of Managing Director Guy Katsav, the firm notably served as the majority shareholder for a healthcare portfolio company that secured a $60 million Series D funding round led by Soleus Capital. Ganot Capital was originally established in 1964 by founder Samuel A. Klurman to manage family wealth.
Key people at Ganot.
Ganot Capital is a privately held, family-owned investment company specializing in healthcare, with over 60 years of experience across buyouts, growth capital, and venture capital.[2] Its portfolio focuses on the senior care sector, including real estate properties, healthcare service companies, medical device firms, digital health, and biopharmaceutical companies, positioning it as a key player in long-term healthcare investments.[2][5]
The firm's mission centers on leveraging deep sector expertise to drive value in healthcare assets, particularly senior living and related innovations, building on a legacy of national leadership in nursing home development.[2]
Ganot Capital traces its roots to Samuel Klurman, who emigrated to the US after World War II and initially worked as a residential real estate developer before pivoting to healthcare real estate.[2] In 1964, Klurman founded Washington Holding Corporation, the predecessor to Ganot, to develop hospitals, nursing homes, and related assets, establishing a foundation in senior care infrastructure.[2] Over decades, the firm evolved under family operation into Ganot Capital, refining its focus on senior living properties and broader healthcare investments while maintaining a privately held structure.[2][5]
Ganot Capital rides the intersecting trends of aging populations and healthtech innovation, where global demographics drive demand for senior care solutions amid rising needs for digital health and biopharma advancements.[2] Its timing aligns with post-WWII healthcare infrastructure booms evolving into modern tech-enabled care, capitalizing on market forces like increasing longevity, chronic disease prevalence, and regulatory support for senior living expansions. By investing across the stack—from real estate to digital tools—Ganot influences the ecosystem by funding scalable models that integrate tech into traditional care, bridging gaps in an underserved sector projected for sustained growth.
Ganot Capital is poised to expand in digital health and biopharma within senior care, as AI-driven personalization, telehealth, and biotech therapies reshape aging services. Trends like value-based care and real estate-tech hybrids will amplify its influence, potentially through larger growth-stage deals amid sector consolidation. Its family-led stability positions it to outlast market cycles, evolving from real estate pioneer to a pivotal backer of tech-infused longevity solutions—reinforcing its foundational role in healthcare's future.
